Form 4: Lemaitre Vascular Director Acquires Shares from PSU Vesting

Joseph P. Pellegrino Jr., a Director at Lemaitre Vascular Inc., acquired 1,897 shares of common stock through the vesting of a Performance Share Unit award and related dividend equivalent rights.

Summary

• Joseph P. Pellegrino Jr., a Director of Lemaitre Vascular Inc. (LMAT), acquired 1,893 shares of common stock on February 26, 2026.
• These shares were acquired upon the settlement of a Performance Share Unit (PSU) award granted on December 6, 2024, with 25% vesting on the transaction date.
• The remaining balance of the PSU award will vest in equal annual installments over the next three years.
• An additional 4 shares of common stock were acquired on the same date due to the release of dividend equivalent rights associated with the PSU vesting.
• Following these transactions, Mr. Pellegrino beneficially owns 12,080 shares of Lemaitre Vascular Inc. common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, as it represents a director increasing their stake through earned compensation, aligning interests with shareholders. It is a routine transaction, not indicative of extraordinary news.

Positives

• The acquisition of shares by a director through a Performance Share Unit award indicates alignment of management interests with shareholder value.
• The vesting of PSUs suggests that performance conditions set for the award have been met, reflecting positively on company performance during the relevant period.

Future Outlook

The remaining balance of the Performance Share Unit award granted on December 6, 2024, is scheduled to vest in equal annual installments over the next three years, indicating future share acquisitions for the reporting person.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as the vesting of equity awards, are common in the medical device industry, reflecting standard executive compensation practices. These transactions typically do not signal significant shifts in company strategy or performance unless they involve unusually large sales or purchases outside of pre-arranged plans.

Comparison to Industry Standards

• The use of Performance Share Units (PSUs) as a component of executive compensation is a common practice across the medical device industry, aligning executive incentives with long-term company performance. Companies like Medtronic, Abbott Laboratories, and Stryker Corporation frequently utilize similar equity-based awards for their executives and directors.
• The vesting schedule, with an initial 25% vesting and subsequent annual installments, is consistent with typical multi-year vesting periods designed to retain talent and encourage sustained performance, comparable to programs seen at peers such as Boston Scientific or Edwards Lifesciences.

Stakeholder Impact

• Shareholders: The increase in director ownership through equity compensation can be viewed positively, as it aligns management's financial interests with long-term shareholder value.
• Employees: The vesting of PSUs demonstrates the company's commitment to performance-based compensation, which can motivate employees.

Next Steps

• The balance of the Performance Share Unit award will vest in equal annual installments over the next three years, implying future share acquisitions for the reporting person on the grant date anniversary.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of a Performance Share Unit award and related dividend equivalent rights. While it shows a director increasing their beneficial ownership, which is generally a positive sign of alignment, it is a pre-scheduled event and does not provide new material information to significantly alter the investment thesis for Lemaitre Vascular Inc. Therefore, a 'hold' recommendation is appropriate as this event alone is unlikely to drive substantial share price movement.

Keywords

Lemaitre Vascular, LMAT, Joseph P Pellegrino Jr, Director, SEC Form 4, Insider Transaction, Performance Share Unit, PSU, Stock Vesting, Equity Compensation, Dividend Equivalent Rights